About
Oct 1 (Reuters) - JCR Pharmaceuticals Co Ltd (4552.T) :* JCR PHARMACEUTICALS ANNOUNCES LICENSING AGREEMENT WITH MENAGEN TO COMMERCIALIZE AGALSIDASE BETA BS I.V. INFUSION (JCR) ACROSS NINE MENAT MARKETS* JCR PHARMACEUTICALS CO LTD: DOES NOT EXPECT A MATERIAL IMPACT ON FY2025 CONSOLIDATED RESULTS FROM MENAGEN DEAL Source text: Further company coverage: (4552.T)(((( Reuters.Briefs@thomsonreuters.com ;));))
